Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The ACR’s 2018 Legislative & Regulatory Priorities

Kelly Tyrrell  |  January 5, 2018

A recent Politico article outlined the looming agenda facing Congress as 2018 begins: Fund the government, raise the debt ceiling, modify spending caps, address healthcare subsidies, allocate additional funds for disaster relief, and address the status of millions of undocumented young immigrants.1 Amid all that activity, the ACR, through its Government Affairs Committee (GAC) and…

Bringing a Public & Private Practice Perspective to the ACR: A conversation with CORC Chair Colin Edgerton, MD, FACP, RhMSUS

Carina Stanton  |  January 5, 2018

Colin Edgerton, MD, FACP, RhMSUS, learned many things during his tenure as a rheumatologist and U.S. Army lieutenant colonel, including how to lead large, facility-based medical operations. Combining this knowledge with his current role as a partner in Articularis Healthcare, the largest single-specialty rheumatology private practice in the U.S., Dr. Edgerton has a unique perspective…

Update on ACR’s Rheumatology-Specific APM

Mary Beth Nierengarten  |  January 5, 2018

Efforts by the ACR to develop a rheumatology-specific alternative payment model (APM) are well under way. The first draft proposal was approved by the ACR Board of Directors in November and presented to the rheumatology community during the 2017 ACR/ARHP Annual Meeting in San Diego. The ACR is pursuing the development of a rheumatology-specific APM…

Meet Chris Adams, MD, the New Chair of the ACR’s Affiliate Society Council

Carol Patton  |  January 4, 2018

What initially strikes people about Christopher Adams, MD, FACP, FACR, is his passion for fairness. In 2015, he told readers of The Rheumatologist, “Patients often feel powerless to fight the system and advocate for themselves, and many of my patients felt they lacked a mechanism for addressing their concerns. That’s where we come in.” Dr….

Neurontin Prescriptions Surge Amid Opioid Crisis

Cindy Devone-Pacheco  |  January 4, 2018

(Reuters Health)—Prescriptions for nerve pain medicines like Neurontin and Lyrica have more than tripled in recent years, driven by increased use among chronically ill older adults and patients already taking opioids, a U.S. study suggests. The proportion of U.S. adults prescribed Neurontin and other drugs in the same family of medicines climbed from 1.2% in…

Trump Administration Rule Would Let More People Drop Obamacare

Yasmeen Abutaleb  |  January 4, 2018

WASHINGTON (Reuters)—The Trump administration proposed a rule on Thursday to allow Americans who are self-employed or work for small businesses to buy health insurance that does not comply with all Obamacare requirements in an effort to unwind the 2010 healthcare law. The rule, put forward by the Department of Labor, would allow individuals and small…

Medical Jargon May Cloud Doctor-Patient Communication

Mary Gillis  |  January 2, 2018

(Reuters Health)—When patients misunderstand commonly used medical terms, communication and decision-making may suffer, U.K. researchers say. In a survey of London oral and maxillofacial surgery clinic patients, more than a third of participants did not know the meaning of such terms as benign or lesion and more than half could not define metastasis or lymph…

New Drug Approvals Hit 21-Year High in 2017

Ben Hirschler  |  January 2, 2018

LONDON (Reuters)—U.S. drug approvals hit a 21-year high in 2017, with 46 novel medicines winning a green light—more than double the previous year—while the figure also rose in the European Union. The European Union (EU) recommended 92 new drugs, including generics, up from 81; and China laid out plans to speed up approvals in what…

Pedometers & RA: Does Increasing Physical Activity Decrease Fatigue?

Arthritis Care & Research  |  January 2, 2018

Recent research examined the effectiveness of a pedometer-based intervention for managing fatigue in patients with rheumatoid arthritis (RA). During the 21-week trial, RA patients using pedometers successfully increased their physical activity, with a greater than 30% decrease in the proportion of participants classified as sedentary. Patients also decreased their reported fatigue, and some reported improvements in function, pain, depressive symptoms and disease activity levels…

Etanercept’s New Autoinjection System; Plus FDA Approves Ixekizumab for Active PsA

Michele B. Kaufman, PharmD, BCGP  |  January 2, 2018

In the U.S., a new formulation and an ergonomic delivery system for single doses of etanercept are now available for RA patients…

  • « Previous Page
  • 1
  • …
  • 369
  • 370
  • 371
  • 372
  • 373
  • …
  • 815
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences